- Home
- CDMO
as 01-17-2025 4:00pm EST
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.
| Founded: | 1981 | Country: | United States |
| Employees: | N/A | City: | TUSTIN |
| Market Cap: | 793.8M | IPO Year: | N/A |
| Target Price: | $12.25 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.90 - $12.48 | Next Earning Date: | 12-10-2024 |
| Revenue: | $150,445,000 | Revenue Growth: | 6.75% |
| Revenue Growth (this year): | 19.05% | Revenue Growth (next year): | 20.88% |
Stock Insider Trading Activity of Avid Bioservices Inc. (CDMO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Richieri Richard A. | CDMO | Chief Operations Officer | Jan 9 '25 | Sell | $12.37 | 2,483 | $30,714.71 | 8,785 | |
| Richieri Richard A. | CDMO | Chief Operations Officer | Dec 25 '24 | Sell | $12.22 | 3,843 | $46,961.46 | 8,785 | |
| Kwietniak Matthew R. | CDMO | Chief Commercial Officer | Dec 25 '24 | Sell | $12.22 | 13,390 | $163,625.80 | 50,796 | |
| Hart Daniel R | CDMO | Chief Financial Officer | Dec 25 '24 | Sell | $12.22 | 22,813 | $278,774.86 | 131,825 | |
| Green Nicholas Stewart | CDMO | President & CEO | Dec 25 '24 | Sell | $12.22 | 145,911 | $1,783,032.42 | 245,856 | |
| Green Nicholas Stewart | CDMO | President & CEO | Dec 20 '24 | Sell | $12.29 | 226,653 | $2,785,374.91 | 245,856 |
Latest Avid Bioservices Inc. News
CDMO Breaking Stock News: Dive into CDMO Ticker-Specific Updates for Smart Investing
GlobeNewswire
10 days ago
Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand
MT Newswires
20 days ago
Avid Bioservices' Waiting Period for Acquisition by GHO, Ampersand Expires
GlobeNewswire
20 days ago
Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand
MT Newswires
20 days ago
Avid Bioservices Insider Sold Shares Worth $1,783,032, According to a Recent SEC Filing
MT Newswires
20 days ago
Avid Bioservices Insider Sold Shares Worth $278,775, According to a Recent SEC Filing
GlobeNewswire
a month ago
Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction
Associated Press Finance
a month ago
Avid Bioservices: Fiscal Q2 Earnings Snapshot
GlobeNewswire
a month ago
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024
Compare CDMO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CDMO Avid Bioservices Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.